- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 271/113 - 1,3,4-OxadiazolesHydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
Patent holdings for IPC class C07D 271/113
Total number of patents in this class: 275
10-year publication summary
|
16
|
26
|
26
|
30
|
22
|
17
|
16
|
18
|
30
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer Cropscience AG | 2136 |
27 |
| King Faisal University | 841 |
16 |
| BASF SE | 20421 |
9 |
| Bayer AG | 3210 |
9 |
| Cytokinetics, Inc. | 268 |
7 |
| Syngenta Crop Protection AG | 4911 |
6 |
| Syngenta Participations AG | 3030 |
5 |
| Bayer Intellectual Property GmbH | 2569 |
5 |
| Abbvie Inc. | 1784 |
5 |
| Vertex Pharmaceuticals Incorporated | 1568 |
5 |
| Oryzon Genomics S.A. | 105 |
5 |
| Calico Life Sciences LLC | 82 |
5 |
| Novartis AG | 11257 |
4 |
| The General Hospital Corporation | 4651 |
4 |
| Northwestern University | 3283 |
4 |
| Microbiotix, Inc. | 40 |
4 |
| The Penn State Research Foundation | 1461 |
4 |
| Romark Laboratories L.C. | 55 |
4 |
| Qingdao Kingagroot Chemical Compound Co., Ltd. | 144 |
4 |
| Glaxo Group Limited | 4258 |
3 |
| Other owners | 140 |